SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-051090
Filing Date
2021-04-16
Accepted
2021-04-16 08:02:32
Documents
4
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2112963-1_def14a.htm DEF 14A 996483
2 GRAPHIC sg_jillmilne-bw.jpg GRAPHIC 12713
3 GRAPHIC tm212419d1-proxy_1pagebw.jpg GRAPHIC 465980
4 GRAPHIC tm212419d1-proxy_2pagebw.jpg GRAPHIC 418799
  Complete submission text file 0001104659-21-051090.txt   2231985
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 21830134
SIC: 2834 Pharmaceutical Preparations